Page last updated: 2024-08-05 13:04:43
prostaglandins D
null
ChEBI ID: 26337
Members (3)
| Member | Definition | Role |
|---|---|---|
| 13,14-dihydro-15-ketoprostaglandin d2 | 13,14-dihydro-15-ketoprostaglandin D2 | |
| prostaglandin d2 | A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- stereoisomer). | prostaglandin D2 |
| prostaglandin d3 | A member of the class of prostaglandins D that is prosta-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,13E,15S,17Z-stereoisomer). | prostaglandin D3 |
Research
Studies (3,388)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 639 (18.86) | 18.7374 |
| 1990's | 676 (19.95) | 18.2507 |
| 2000's | 1,236 (36.48) | 29.6817 |
| 2010's | 721 (21.28) | 24.3611 |
| 2020's | 116 (3.42) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 78 (2.24%) | 5.53% |
| Reviews | 222 (6.38%) | 6.00% |
| Case Studies | 23 (0.66%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 3,158 (90.72%) | 84.16% |